Genetics

This blog post examines how modern genetic and functional genomic research is reshaping our understanding of multiple sclerosis (MS). It explores the polygenic architecture of disease susceptibility, the central role of HLA and non-HLA risk loci, and the growing importance of regulatory genomics, single-cell biology, and multi-omics approaches in identifying the molecular and cellular mechanisms that drive MS pathogenesis. Framed in formal scientific language, the article highlights how these advances are moving the field beyond association studies toward clinically meaningful insights in diagnosis, stratification, and therapeutic development.